Skip to content
Open access · OA via OpenAlex

TARGETING PRO-INFLAMMATORY CELLS IN IDIOPATHIC PULMONARY FIBROSIS: AN OPEN-LABEL PILOT STUDY OF DASATINIB AND QUERCETIN

Anoop M. Nambiar, Jamie Nicole Justice, Rodolfo M. Pascual, Tamar Tchkonia, Nathan K. LeBrasseur, James L. Kirkland, Nicolas Musi, Stephen B. Kritchevsky

CHEST Journal · 2018 · ▲ 1 citations

Abstract

This 2018 study published in CHEST Journal reports on an open-label pilot trial investigating the use of dasatinib and quercetin in pulmonary fibrosis.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1016/j.chest.2018.08.365
Canonical
link ↗
Fetched
2026-10-08 MST

Cite this

APA
Nambiar, A.M., Justice, J.N., Pascual, R.M., Tchkonia, T., LeBrasseur, N.K., Kirkland, J.L., Musi, N., &amp; Kritchevsky, S.B. (2018). TARGETING PRO-INFLAMMATORY CELLS IN IDIOPATHIC PULMONARY FIBROSIS: AN OPEN-LABEL PILOT STUDY OF DASATINIB AND QUERCETIN. <em>CHEST Journal</em>. https://doi.org/10.1016/j.chest.2018.08.365
Vancouver
Nambiar AM, Justice JN, Pascual RM, Tchkonia T, LeBrasseur NK, Kirkland JL, et al. TARGETING PRO-INFLAMMATORY CELLS IN IDIOPATHIC PULMONARY FIBROSIS: AN OPEN-LABEL PILOT STUDY OF DASATINIB AND QUERCETIN. CHEST Journal. 2018. doi:10.1016/j.chest.2018.08.365.
BibTeX
@article{anoop2018TARGET, title = {TARGETING PRO-INFLAMMATORY CELLS IN IDIOPATHIC PULMONARY FIBROSIS: AN OPEN-LABEL PILOT STUDY OF DASATINIB AND QUERCETIN}, author = {Anoop M. Nambiar and Jamie Nicole Justice and Rodolfo M. Pascual and Tamar Tchkonia and Nathan K. LeBrasseur and James L. Kirkland and Nicolas Musi and Stephen B. Kritchevsky}, journal = {CHEST Journal}, year = {2018}, doi = {10.1016/j.chest.2018.08.365}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings